🔗 Share this article

The Nobel Prize in medical science was awarded for transformative findings that clarify how the immune system attacks dangerous infections while sparing the healthy tissues.

Three renowned researchers—from Japan Prof. Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—share this accolade.

The work identified unique "sentinels" within the immune system that eliminate rogue immune cells that could harming the body.

The findings are now paving the way for innovative therapies for immune disorders and cancer.

The laureates will divide a monetary award worth 11m Swedish kronor.

Crucial Findings

"Their research has been decisive for understanding how the immune system operates and the reason we don't all suffer from serious autoimmune diseases," commented the chair of the award panel.

The trio's research explain a fundamental question: How does the defense system protect us from numerous invaders while leaving our own tissues unharmed?

The body's protection system employs immune cells that scan for signs of disease, including viruses and bacteria it has never encountered.

Such defenders employ sensors—called receptors—that are produced randomly in countless combinations.

This provides the defense network the capacity to combat a broad range of threats, but the randomness of the process inevitably creates white blood cells that can attack the body.

Security Guards of the Immune System

Scientists previously knew that a portion of these harmful white blood cells were destroyed in the immune organ—where white blood cells develop.

This year's Nobel Prize recognizes the discovery of T-reg cells—known as the body's "peacekeepers"—which patrol the system to disarm any defenders that assault the body's own tissues.

It is known that this process malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

A prize committee stated, "The findings have established a new field of research and accelerated the creation of new therapies, for instance for tumors and immune disorders."

In malignancies, T-regs prevent the system from attacking the growth, so research are aimed at lowering their quantity.

For autoimmune diseases, experiments are testing boosting T-reg cells so the body is not under attack. A similar method could also be effective in reducing the risks of organ transplant rejection.

Pioneering Experiments

Professor Sakaguchi, of a Japanese institution, conducted tests on mice that had their thymus extracted, causing self-attack conditions.

The researcher showed that introducing defense cells from healthy animals could stop the disease—implying there was a mechanism for blocking defenders from harming the body.

Mary Brunkow, from the a research center in a US city, and Fred Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were investigating an genetic autoimmune disease in mice and humans that resulted in the discovery of a gene vital for how regulatory T-cells operate.

"The groundbreaking work has revealed how the immune system is controlled by regulatory T cells, preventing it from accidentally targeting the body's own tissues," commented a leading biological science specialist.

"This research is a remarkable illustration of how basic biological study can have far-reaching implications for human health."